Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 29, 2012 | March 02, 2012 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | November 19, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 29, 2012 · Filed March 02, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 144,311 |
Ending reported balance
After 2012-03-01 transaction · row 24
24 source rows · reconciled sequenceRow 1 · 2012-02-29 · Sale · Disposed 4,900 · Balance 220,896 Row 2 · 2012-02-29 · Sale · Disposed 5,750 · Balance 215,146 Row 3 · 2012-02-29 · Sale · Disposed 700 · Balance 214,446 Row 4 · 2012-02-29 · Sale · Disposed 4,115 · Balance 210,331 Row 5 · 2012-02-29 · Sale · Disposed 200 · Balance 210,131 Row 6 · 2012-02-29 · Sale · Disposed 15,135 · Balance 194,996 Row 7 · 2012-02-29 · Sale · Disposed 12,318 · Balance 182,678 Row 8 · 2012-02-29 · Sale · Disposed 2,800 · Balance 179,878 Row 9 · 2012-02-29 · Sale · Disposed 2,300 · Balance 177,578 Row 10 · 2012-02-29 · Sale · Disposed 4,403 · Balance 173,175 Row 11 · 2012-02-29 · Sale · Disposed 200 · Balance 172,975 Row 12 · 2012-02-29 · Sale · Disposed 3,697 · Balance 169,278 Row 13 · 2012-02-29 · Sale · Disposed 2,200 · Balance 167,078 Row 14 · 2012-02-29 · Sale · Disposed 100 · Balance 166,978 Row 15 · 2012-02-29 · Sale · Disposed 1,560 · Balance 165,418 Row 16 · 2012-02-29 · Sale · Disposed 100 · Balance 165,318 Row 17 · 2012-02-29 · Sale · Disposed 100 · Balance 165,218 Row 18 · 2012-02-29 · Sale · Disposed 4,300 · Balance 160,918 Row 19 · 2012-02-29 · Sale · Disposed 700 · Balance 160,218 Row 20 · 2012-02-29 · Sale · Disposed 907 · Balance 159,311 Row 21 · 2012-03-01 · Sale · Disposed 3,737 · Balance 155,574 Row 22 · 2012-03-01 · Sale · Disposed 7,000 · Balance 148,574 Row 23 · 2012-03-01 · Sale · Disposed 100 · Balance 148,474 Row 24 · 2012-03-01 · Sale · Disposed 4,163 · Balance 144,311 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 6,660 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 25
Holding and transaction disclosures are not merged.
1 source rowRow 25 · Balance 6,660 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife | 20,400 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 26
Holding and transaction disclosures are not merged.
1 source rowRow 26 · Balance 20,400 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 27
Holding and transaction disclosures are not merged.
1 source rowRow 27 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 28
Holding and transaction disclosures are not merged.
1 source rowRow 28 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012.
F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date November 19, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 26,123 |
Reported balance
After 2021-11-19 transaction · row 1
1 source rowRow 1 · 2021-11-19 · Grant · Acquired 4,271 · Balance 26,123 F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $56.79 | $34,075.20 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,781 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,444 | $56.80 | $309,230.09 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,381 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $56.79 | $39,753.70 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,825 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,842 | $52.66 | $254,979.72 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,902 | $52.55 | $99,950.10 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2007 Filed Jan 2, 2008 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,260 | $57.23 | $72,109.80 |
DisclosureSEC source: 0001104659-08-000232 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,781 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 47,547 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,547 Underlying: Common shares · 47,547 shares Expires 2013-02-13 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 18,564 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,564 Underlying: Common shares · 18,564 shares Expires 2010-02-10 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 21,473 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,664 Underlying: Common shares · 21,473 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 60,792 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: Common shares · 60,792 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 13,245 | $51.60 | $683,428.76 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,041 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 66,111 | $51.91 | $3,431,822.01 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,286 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 24,538 | $32.61 | $800,211.17 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 60,792 | $33.23 | $2,020,203.27 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,519 | $52.49 | $132,222.31 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,067 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 980 | $52.49 | $51,440.20 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,586 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,449 | $52.49 | $128,548.01 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,566 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009, and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,015 F3 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,015 F2 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,366 | $52.70 | $440,888.20 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,615 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,200 | $52.80 | $116,160.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,981 F1 · kind: This sale was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). This plan was adopted on February 1, 2007. Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,273 | $0.00 Strike: $47.33 | $0.00 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · derivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,273 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,119 | $0.00 Strike: $47.33 | $0.00 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · derivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,119 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,392 | $52.67 | $283,980.46 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,181 Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,392 | $47.33 | $255,203.36 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,704 | $52.90 | $90,136.49 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,181 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,217 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 18 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217 Underlying: Common shares · 1,217 shares Expires 2008-06-29 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 4,842 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 17 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,842 Underlying: Common shares · 4,842 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,488 | $0.00 Strike: $39.04 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 16 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common shares · 1,488 shares Expires 2008-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,275 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 15 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,275 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,059 | $52.66 | $319,066.94 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,885 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,488 | $39.04 | $58,090.48 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,275 | $34.77 | $218,198.69 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,902 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 14 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,902 Underlying: Common shares · 1,902 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 13 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,275 Underlying: Common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 85 | $0.00 Strike: $31.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 12 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 85 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,907 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,907 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,513 | $52.55 | $237,158.15 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,181 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 85 | $31.43 | $2,671.30 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,907 | $27.43 | $134,612.75 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 26,000 | $0.00 Strike: $48.76 | $0.00 |
DisclosureSEC source: 0001104659-07-000370 · a4.xml · derivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common shares · 26,000 shares Expires 2016-12-28 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,667 on 12/29/2007, 8,667 on 12/29/2008, and 8,666 on 12/29/2009. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-000370 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,927 F1 · balance_after: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 29, 2006 Filed Feb 1, 2007 23:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,827 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.